109 related articles for article (PubMed ID: 14993256)
21. Pharmacodynamic mechanisms of monoclonal antibody-based antagonism of (+)-methamphetamine in rats.
Byrnes-Blake KA; Laurenzana EM; Carroll FI; Abraham P; Gentry WB; Landes RD; Owens SM
Eur J Pharmacol; 2003 Feb; 461(2-3):119-28. PubMed ID: 12586207
[TBL] [Abstract][Full Text] [Related]
22. Treatment of rats with an anti-(+)-methamphetamine monoclonal antibody shortens the duration of action of repeated (+)-methamphetamine challenges over a one month period.
Hambuchen MD; Rüedi-Bettschen D; Williams DK; Hendrickson H; Owens SM
Vaccine; 2014 Oct; 32(47):6213-9. PubMed ID: 25252196
[TBL] [Abstract][Full Text] [Related]
23. Development and preclinical testing of a high-affinity single-chain antibody against (+)-methamphetamine.
Peterson EC; Laurenzana EM; Atchley WT; Hendrickson HP; Owens SM
J Pharmacol Exp Ther; 2008 Apr; 325(1):124-33. PubMed ID: 18192498
[TBL] [Abstract][Full Text] [Related]
24. Combining Active Immunization with Monoclonal Antibody Therapy To Facilitate Early Initiation of a Long-Acting Anti-Methamphetamine Antibody Response.
Hambuchen MD; Carroll FI; Rüedi-Bettschen D; Hendrickson HP; Hennings LJ; Blough BE; Brieaddy LE; Pidaparthi RR; Owens SM
J Med Chem; 2015 Jun; 58(11):4665-77. PubMed ID: 25973614
[TBL] [Abstract][Full Text] [Related]
25. Development of murine monoclonal antibodies to methamphetamine and methamphetamine analogues.
Danger Y; Gadjou C; Devys A; Galons H; Blanchard D; Folléa G
J Immunol Methods; 2006 Feb; 309(1-2):1-10. PubMed ID: 16412457
[TBL] [Abstract][Full Text] [Related]
26. Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis.
Cui X; Li Y; Moayeri M; Choi GH; Subramanian GM; Li X; Haley M; Fitz Y; Feng J; Banks SM; Leppla SH; Eichacker PQ
J Infect Dis; 2005 Feb; 191(3):422-34. PubMed ID: 15633102
[TBL] [Abstract][Full Text] [Related]
27. Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines.
Duryee MJ; Bevins RA; Reichel CM; Murray JE; Dong Y; Thiele GM; Sanderson SD
Vaccine; 2009 May; 27(22):2981-8. PubMed ID: 19428909
[TBL] [Abstract][Full Text] [Related]
28. Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine.
Fukami G; Hashimoto K; Koike K; Okamura N; Shimizu E; Iyo M
Brain Res; 2004 Jul; 1016(1):90-5. PubMed ID: 15234256
[TBL] [Abstract][Full Text] [Related]
29. Effect of SCH 23390 on (+/-)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats.
Daniela E; Brennan K; Gittings D; Hely L; Schenk S
Pharmacol Biochem Behav; 2004 Apr; 77(4):745-50. PubMed ID: 15099919
[TBL] [Abstract][Full Text] [Related]
30. Human pharmacology of the methamphetamine stereoisomers.
Mendelson J; Uemura N; Harris D; Nath RP; Fernandez E; Jacob P; Everhart ET; Jones RT
Clin Pharmacol Ther; 2006 Oct; 80(4):403-20. PubMed ID: 17015058
[TBL] [Abstract][Full Text] [Related]
31. Administration of monoclonal antibodies neutralizing the inflammatory mediators tumor necrosis factor alpha and interleukin -6 does not attenuate acute behavioral deficits following experimental traumatic brain injury in the rat.
Marklund N; Keck C; Hoover R; Soltesz K; Millard M; LeBold D; Spangler Z; Banning A; Benson J; McIntosh TK
Restor Neurol Neurosci; 2005; 23(1):31-42. PubMed ID: 15846030
[TBL] [Abstract][Full Text] [Related]
32. Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration.
Rothman RB; Blough BE; Woolverton WL; Anderson KG; Negus SS; Mello NK; Roth BL; Baumann MH
J Pharmacol Exp Ther; 2005 Jun; 313(3):1361-9. PubMed ID: 15761112
[TBL] [Abstract][Full Text] [Related]
33. Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity.
Truong JG; Wilkins DG; Baudys J; Crouch DJ; Johnson-Davis KL; Gibb JW; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2005 Sep; 314(3):1087-92. PubMed ID: 15901804
[TBL] [Abstract][Full Text] [Related]
34. L-methamphetamine and selective MAO inhibitors decrease morphine-reinforced and non-reinforced behavior in rats; Insights towards selegiline's mechanism of action.
He S; Grasing K
Pharmacol Biochem Behav; 2006 Dec; 85(4):675-88. PubMed ID: 17157368
[TBL] [Abstract][Full Text] [Related]
35. The anti-(+)-methamphetamine monoclonal antibody mAb7F9 attenuates acute (+)-methamphetamine effects on intracranial self-stimulation in rats.
Harris AC; LeSage MG; Shelley D; Perry JL; Pentel PR; Owens SM
PLoS One; 2015; 10(3):e0118787. PubMed ID: 25742165
[TBL] [Abstract][Full Text] [Related]
36. Functional and biological determinants affecting the duration of action and efficacy of anti-(+)-methamphetamine monoclonal antibodies in rats.
Laurenzana EM; Hendrickson HP; Carpenter D; Peterson EC; Gentry WB; West M; Che Y; Carroll FI; Owens SM
Vaccine; 2009 Nov; 27(50):7011-20. PubMed ID: 19800446
[TBL] [Abstract][Full Text] [Related]
37. Preclinical characterization of an anti-methamphetamine monoclonal antibody for human use.
Stevens MW; Tawney RL; West CM; Kight AD; Henry RL; Owens SM; Gentry WB
MAbs; 2014; 6(2):547-55. PubMed ID: 24492290
[TBL] [Abstract][Full Text] [Related]
38. The effect of a chimeric human/murine anti-cocaine monoclonal antibody on cocaine self-administration in rats.
Norman AB; Norman MK; Buesing WR; Tabet MR; Tsibulsky VL; Ball WJ
J Pharmacol Exp Ther; 2009 Mar; 328(3):873-81. PubMed ID: 19088302
[TBL] [Abstract][Full Text] [Related]
39. [Biological fate of 3H-labeled penfluridol. (3) Correlation between concentration of 3H-penfluridol in the brain and its anti-methamphetamine activity].
Nakamura S; Ishida R; Sugihara J
Radioisotopes; 1976 Oct; 25(10):637-40. PubMed ID: 1037406
[TBL] [Abstract][Full Text] [Related]
40. [N-alkyl effect of methamphetamine analogs on the reactivity to anti-methamphetamine antibody].
Yoshii T; Mukaida M; Mori A; Ishiyama I
Nihon Hoigaku Zasshi; 1987 Aug; 41(4):342-6. PubMed ID: 3320421
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
